why have i not lost weight on semaglutide am losing (Ozempic/Wegovy)? Wegovy Before and After: Real

The primary outcome assessed was the change in HbA1c levels from baseline to week 40 ( 4.3 SURPASS-3 trial comparison of tirzepatide and insulin degludec The SURPASS-3 trial involved 1,444 patients with type 2 diabetes who had HbA1c levels ranging from 7% to 10.5% and a BMI of 25 kg/m 2 or higher

[Source: ITV] Read more insights on how pub chefs are going back to basics, shrinkflation frustration, the premium pizza boom, how Brits are confused by nutrition and more, HERE.

GLP-1R activation is neuroprotective in cellular and animal models of dopaminergic degeneration (Jones-Tabah, 2022)

GLP-1 medications are primarily used to treat type 2 diabetes and are also prescribed for chronic weight management in patients with obesity or related health risks